This is a research study to examine the effectiveness of a brief screening method that may
predict which people with posttraumatic stress disorder (PTSD) are most likely to show a
positive response to selective serotonin reuptake inhibitor (SSRI) medications. Participants
will be recruited over approximately 3.25 years, until at least 94 participants complete the
17 week study.
Phase:
Phase 4
Details
Lead Sponsor:
VA Office of Research and Development
Collaborators:
Massachusetts General Hospital Middlebury College Suffolk University